212 related articles for article (PubMed ID: 22377254)
1. Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience.
Kang SH; Park HS; Sun IO; Choi SR; Chung BH; Choi BS; Min CK; Do JY; Yang CW; Kim YS; Yoon KW; Park CW
Clin Nephrol; 2012 Mar; 77(3):225-30. PubMed ID: 22377254
[TBL] [Abstract][Full Text] [Related]
2. Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute.
Jo T; Arai Y; Kondo T; Kitano T; Hishizawa M; Yamashita K; Takaori-Kondo A
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2159-2165. PubMed ID: 28822830
[TBL] [Abstract][Full Text] [Related]
3. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation.
Pedersen SJV; Monagel DA; Mammen C; Lewis VA; Guilcher GMT; Bruce AA
Pediatr Blood Cancer; 2020 Sep; 67(9):e28568. PubMed ID: 32672896
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation.
Lugthart G; Jordans CCE; de Pagter APJ; Bresters D; Jol-van der Zijde CM; Bense JE; van Rooij-Kouwenhoven RWG; Sukhai RN; Louwerens M; Dorresteijn EM; Lankester AC
Kidney Int; 2021 Oct; 100(4):906-914. PubMed ID: 34102218
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
[TBL] [Abstract][Full Text] [Related]
6. Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study.
Touzot M; Elie C; van Massenhove J; Maillard N; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2010 Feb; 25(2):624-7. PubMed ID: 19828460
[TBL] [Abstract][Full Text] [Related]
7. Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.
Kang SH; Hwang HS; Park HS; Sun IO; Choi SR; Chung BH; Choi BS; Yang CW; Kim YS; Min CK; Park CW
J Korean Med Sci; 2011 Oct; 26(10):1310-5. PubMed ID: 22022183
[TBL] [Abstract][Full Text] [Related]
8. Survival after acute kidney injury requiring dialysis: long-term follow up.
Duran PA; Concepcion LA
Hemodial Int; 2014 Oct; 18 Suppl 1():S1-6. PubMed ID: 25330825
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of acute and chronic renal function in children following matched related donor hematopoietic stem cell transplantation.
Ileri T; Ertem M; Ozcakar ZB; Ince EU; Biyikli Z; Uysal Z; Ekim M; Yalcinkaya F
Pediatr Transplant; 2010 Feb; 14(1):138-44. PubMed ID: 19413721
[TBL] [Abstract][Full Text] [Related]
10. Continued monitoring of acute kidney injury survivors might not be necessary in those regaining an estimated glomerular filtration rate >60 mL/min at 1 year.
Stoumpos S; Mark PB; McQuarrie EP; Traynor JP; Geddes CC
Nephrol Dial Transplant; 2017 Jan; 32(1):81-88. PubMed ID: 28391314
[TBL] [Abstract][Full Text] [Related]
11. Outcome predictors of allogeneic hematopoietic stem cell transplant.
Yang WC; Chen YT; Chang WW; Chang CH; Fan PC; Lee SY; Kao KC; Tian YC; Hung CC; Fang JT; Yang CW; Chen YC; Wang PN
Am J Med Sci; 2013 Jan; 345(1):33-8. PubMed ID: 22475735
[TBL] [Abstract][Full Text] [Related]
12. Delayed renal dysfunction after total body irradiation in pediatric malignancies.
Watanabe Nemoto M; Isobe K; Togasaki G; Kanazawa A; Kurokawa M; Saito M; Harada R; Kobayashi H; Ito H; Uno T
J Radiat Res; 2014 Sep; 55(5):996-1001. PubMed ID: 24914103
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
Kersting S; Hené RJ; Koomans HA; Verdonck LF
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
[TBL] [Abstract][Full Text] [Related]
14. Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population.
Zhou W; Sultana R; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Koh LP; Koh M; Loh Y; Tan P; Linn YC
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28135776
[TBL] [Abstract][Full Text] [Related]
15. Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Piñana JL; Valcárcel D; Martino R; Barba P; Moreno E; Sureda A; Vega M; Delgado J; Briones J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Jan; 15(1):21-9. PubMed ID: 19135939
[TBL] [Abstract][Full Text] [Related]
16. The use of low doses of methotrexate during peri-cell infusion period may be a risk factor for acute kidney injury in patients subjected to hematopoietic stem cell transplantation.
Ferraz FTP; Marra AR; Hamerschlak N; de Souza Durão Junior M
Ann Hematol; 2020 Mar; 99(3):627-633. PubMed ID: 31965273
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.
Chan GS; Lam MF; Au WY; Chim S; Tse KC; Lo SH; Fung SH; Lai KN; Chan KW
Nephrology (Carlton); 2008 Jun; 13(4):322-30. PubMed ID: 18221254
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of renal function in children after stem cell transplantation measured by estimated glomerular filtration rate.
Ukeba-Terashita Y; Kobayashi R; Hori D; Matsushima S; Sano H; Suzuki D; Nakajima M; Suzuki M; Ueno M; Fujita S; Kobayashi K
Pediatr Blood Cancer; 2019 Feb; 66(2):e27478. PubMed ID: 30350912
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective study of kidney insufficiency in adult patients after myeloablative allogeneic hematopoietic stem cell transplantation].
Luo CW; DU X; Weng JY; Wu SJ; Guo R; Lu ZS; Ling W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):671-5. PubMed ID: 22739180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
